Avanos Medical, Inc. (NYSE:AVNS – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $15.51 and last traded at $15.68, with a volume of 21611 shares traded. The stock had previously closed at $15.92.
Analyst Ratings Changes
Separately, StockNews.com lowered Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.
View Our Latest Report on Avanos Medical
Avanos Medical Trading Up 2.2 %
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Quarry LP bought a new stake in Avanos Medical during the third quarter valued at about $42,000. KBC Group NV boosted its stake in Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the period. Canada Pension Plan Investment Board acquired a new stake in Avanos Medical in the 2nd quarter valued at approximately $70,000. XTX Topco Ltd bought a new position in Avanos Medical in the 2nd quarter worth approximately $202,000. Finally, Intech Investment Management LLC acquired a new position in shares of Avanos Medical during the third quarter worth approximately $207,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
See Also
- Five stocks we like better than Avanos Medical
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 Stocks Helping to Bring AI to Healthcare
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.